General MedicationsOPHTHALMICGeneric

CYCLOPENTOLATE HYDROCHLORIDE

Standard Dose

0.5%

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview CYCLOPENTOLATE HYDROCHLORIDE is listed in Drugs@FDA under application 205937 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CYCLOPENTOLATE HYDROCHLORIDE Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.5% Sponsor SCIEGEN PHARMS Submission history Latest submission status date: 2015-12-09 00:00:00.

Structured Monograph

Clinical summary

Approval overview CYCLOPENTOLATE HYDROCHLORIDE is listed in Drugs@FDA under application 205937 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CYCLOPENTOLATE HYDROCHLORIDE Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.5% Sponsor SCIEGEN PHARMS Submission history Latest submission status date: 2015-12-09 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.